Jump to section
To make the world's health data secure, accessible, and actionable.
44% employee growth in 12 months
Datavant’s healthcare data platform leverages AI to allow medical companies to organize, protect, match, interpret and share data for use in clinical trial decision making. Founded in 2017, it has an impressive list of clients including Janssen, Symphony Health, Medidata and Blue Health Intelligence.
The market in which Datavant operates is booming, as global big data analytics in healthcare is forecast to be worth around $60 billion by 2026, up from $16 billion in 2017.
Having raised significant venture funding from Transformation Capital and notably, Johnson & Johnson Innovation, the company has since gone on to form a $7 billion merger with peer company Ciox Health. This move makes Datavant the largest health data ecosystem in the US. It isn't slowing down either, having since acquired more companies.
Kirsty
Company Specialist at Welcome to the Jungle
Oct 2020
$40m
SERIES B
Apr 2018
$40.5m
EARLY VC
Total funding
This company has top investors
Kyle Armbrester
(CEO)Previously spent 6 years at Signify Health as the CEO. Prior to that, they spent 7 years at athenahealth as a VP of Strategy & Corporate Development then as the Senior VP/CPO.